Bulgarian Drug Maker Sopharma H1 Sales Fall 6.0%

Bulgarian Drug Maker Sopharma H1 Sales Fall 6.0%

Bulgarian drug maker Sopharma [BUL:3JR] said on Friday its sales revenue fell 6.0% on the year in the January-June period.
Domestic sales increased by 2.0% in the first six months of 2014, while exports went down by 8.0%, Sopharma said in a press release.
In June alone, Sopharma’s sales decreased by 8.0% on the year as domestic sales dropped by 7.0% and exports fell 9.0% mainly due to the situation in eastern Ukraine, the company said.

Previous Next
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.